HCW Biologics (HCWB) Long-Term Debt Repayments (2023 - 2025)
Historic Long-Term Debt Repayments for HCW Biologics (HCWB) over the last 3 years, with Q3 2025 value amounting to -$31391.0.
- HCW Biologics' Long-Term Debt Repayments fell 619.78% to -$31391.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$125786.0, marking a year-over-year decrease of 688.82%. This contributed to the annual value of -$119398.0 for FY2024, which is 21196.4% down from last year.
- Latest data reveals that HCW Biologics reported Long-Term Debt Repayments of -$31391.0 as of Q3 2025, which was down 619.78% from -$30925.0 recorded in Q2 2025.
- In the past 5 years, HCW Biologics' Long-Term Debt Repayments registered a high of -$8981.0 during Q3 2023, and its lowest value of -$32460.0 during Q1 2025.
- In the last 3 years, HCW Biologics' Long-Term Debt Repayments had a median value of -$29706.0 in 2024 and averaged -$28049.7.
- Data for HCW Biologics' Long-Term Debt Repayments shows a peak YoY increase of 586.51% (in 2024) and a maximum YoY decrease of 22912.82% (in 2024) over the last 5 years.
- Over the past 3 years, HCW Biologics' Long-Term Debt Repayments (Quarter) stood at -$29292.0 in 2023, then dropped by 5.87% to -$31010.0 in 2024, then decreased by 1.23% to -$31391.0 in 2025.
- Its Long-Term Debt Repayments was -$31391.0 in Q3 2025, compared to -$30925.0 in Q2 2025 and -$32460.0 in Q1 2025.